SGLTR-M Tablet 10's
₹157.1*
MRP ₹174.5
10% off
₹148.5*
MRP ₹174.5
15% CB
₹26 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
SGLTR-M Tablet belongs to the group of anti-diabetic medicines used to treat type-2 diabetes mellitus adjunct to diet and exercise. Type-2 diabetes mellitus is also known as non-insulin-dependent diabetes or adult-onset diabetes. It is a medical condition in which blood glucose levels are above normal due to insulin deficiency, insulin resistance, or both.
SGLTR-M Tablet is a combination of two drugs, namely: Remogliflozin etabonate and Metformin hydrochloride. Remogliflozin etabonate helps in removing excess sugar from the body via urine. Metformin hydrochloride works by reducing the sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the body's sensitivity to insulin. Together, SGLTR-M Tablet helps control blood sugar levels.
You are advised to take SGLTR-M Tablet for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side effects such as stomach upset, hypoglycaemia, nausea, and vomiting. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to consult your doctor if the side effects persist or worsen.
Consult your doctor if you are pregnant or breastfeeding. Avoid alcohol consumption while taking SGLTR-M Tablet as it might cause unpleasant side-effects. Limited information is available regarding the usage of SGLTR-M Tablet in children, so please consult a doctor if you have any concerns. Inform your doctor about all the medicines you are taking and your health condition to rule out any unpleasant side effects/interactions.
SGLTR-M Tablet is a combination of two anti-diabetic drugs, namely: Remogliflozin etabonate and Metformin hydrochloride. SGLTR-M Tablet is used to treat type-2 diabetes mellitus. Remogliflozin etabonate helps in removing excess sugar from the body via urine. Metformin hydrochloride reduces sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the body's sensitivity to insulin. Together, SGLTR-M Tablet helps control blood sugar levels.
Do not take SGLTR-M Tablet if you are allergic to any of its contents. Inform your doctor if you have heart problems, diabetic ketoacidosis, skin problems, acute pancreatitis, low blood sugar levels, kidney or liver problems. Consult your doctor if you are pregnant or breastfeeding. Avoid alcohol consumption while taking SGLTR-M Tablet as it might cause unpleasant side-effects. Inform your doctor about all the medicines you are taking and your health condition to rule out any unpleasant side effects.
Drug-Drug Interactions: SGLTR-M Tablet may interact with anti-diabetic medicines (insulin glargine), diuretics (furosemide), and hormones (levothyroxine).
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interactions: Inform your doctor if you have diabetic ketoacidosis, dialysis, skin disorder, acute pancreatitis, or hypoglycaemia (low blood sugar levels).
Type-2 diabetes mellitus: It is also known as non-insulin-dependent diabetes. It is a chronic or lifelong disease that keeps the body from utilizing insulin properly. Diabetes is a medical condition in which blood glucose levels are above normal. People with type 2 diabetes either do not produce enough insulin, or the insulin produced cannot perform its function in the body (insulin resistance). Middle-aged or older individuals are most likely to suffer from type 2 diabetes; hence it is also known as adult-onset diabetes. Type 2 diabetes symptoms include lack of energy, tiredness, frequent urination, excess thirst, dry mouth, blurry vision, constant hunger, and weight loss.
Alcohol
Caution
You are recommended to avoid alcohol consumption while taking SGLTR-M Tablet to prevent unpleasant side effects.
Pregnancy
Caution
Please consult your doctor if you have any concerns regarding this; your doctor will prescribe only if the benefits outweigh the risks.
Breast Feeding
Caution
Please consult your doctor if you have any concerns regarding this; your doctor will decide whether SGLTR-M Tablet can be given to breastfeeding mothers or not.
Driving
Caution
It is not known if SGLTR-M Tablet affects your ability to drive. Drive or operate machinery only if you are alert.
Liver
Caution
Dose adjustment may be needed. Please consult your doctor if you have a liver impairment or any concerns regarding this.
Kidney
Caution
Dose adjustment may be needed. Please consult your doctor if you have kidney impairment or any concerns regarding this.
Children
Caution
Limited information is available regarding the usage of SGLTR-M Tablet in children, so please consult a doctor.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Customers Also Bought
Recommended for a 30-day course: 3 Strips